Xeris Biopharma Holdings, Inc. XERS
NASDAQ · United States · Health Technology
$9.25-0.31 (-3.24%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.18 | 0.01 | -1,582.3% | $91.00M | +1.0% | -2.2%$8.11→$7.93 |
| Q1 2026 | 2026-05-07 | 0.01 | 0.00 | — | — | — | +2.5%$6.37→$6.53 |
| Q4 2025 | 2026-03-02 | 0.06 | 0.05 | +20.0% | — | — | -2.9%$6.12→$5.94 |
| Q3 2025 | 2025-11-06 | 0.00 | 0.00 | — | — | — | -24.7%$9.87→$7.43 |
| Q2 2025 | 2025-08-07 | -0.01 | -0.03 | +66.7% | — | — | — |
| Q1 2025 | 2025-05-08 | -0.06 | -0.04 | -50.0% | — | — | — |
| Q4 2024 | 2025-03-06 | -0.03 | -0.02 | -50.0% | — | — | — |
| Q3 2024 | 2024-11-08 | -0.06 | -0.08 | +25.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.